<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04750902</url>
  </required_header>
  <id_info>
    <org_study_id>CRO-2020-CAR-ARG-ED</org_study_id>
    <nct_id>NCT04750902</nct_id>
  </id_info>
  <brief_title>A Clinical Trial to Assess the Safety and the Anti-caries Efficacy of COL 101 (Arginine) Non-fluoride Dentifrices in Comparison With 0.24% Sodium Fluoride (1100 Ppm F) Dentifrice Control in 10 to 14-year-old Children</brief_title>
  <official_title>A Phase 2 Randomized, Double-blind, Active-controlled Multi-center Clinical Trial to Assess the Safety and the Anti-caries Efficacy of COL 101 (Arginine) Non-fluoride Dentifrices With 1.5%, 4.0% and 8.0% Arginine Each in Comparison With 0.24% Sodium Fluoride (1100 Ppm F) Dentifrice Control in 10 to 14-year-old Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Colgate Palmolive</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Colgate Palmolive</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to assess the safety and to evaluate the anti-caries efficacy&#xD;
      of COL101 (arginine) non-fluoride dentifrices compared to a 0.24% sodium fluoride dentifrice&#xD;
      in 10-14 year-old children over a one year period.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 21, 2021</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary efficacy endpoint will be the incremental subject-wise Decayed Missing Filled Surfaces (DMFS) score after one year of product use</measure>
    <time_frame>one year</time_frame>
    <description>the minimum score is 0, maximum score is 4/5 depending on the tooth number and a higher score represents a worse outcome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incremental subject-wise Decayed Missing Filled Surfaces (DFMS) score after 6-months of product use;</measure>
    <time_frame>after 6 months</time_frame>
    <description>the minimum score is 0, maximum score is 4/5 depending on the tooth number and a higher score represents a worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incremental subject-wise Decayed Missing Filled Surfaces (DFMS) score between 6- months and one year of product use.</measure>
    <time_frame>between 6-months and one year</time_frame>
    <description>the minimum score is 0, maximum score is 4/5 depending on the tooth number and a higher score represents a worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinically significant change in International Caries Detection and Assessment System (ICDAS) severity scores between the baseline and the six-month and one-year examinations and between the six-month and one-year examinations.</measure>
    <time_frame>between 6-months and one year</time_frame>
    <description>the minimum score is 0, maximum score is 6 and a higher score represents a worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinically significant changes indicating caries progression are changes in ICDAS severity values from 0 to 2 or higher, from 1 or 2 to 3 or higher, or from 3 or 4 to 5 or 6.</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinically significant changes indicating caries regression are changes in ICDAS severity values from 2 or higher to 0 or 1.</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Dental Caries</condition>
  <arm_group>
    <arm_group_label>0.24% Sodium Fluoride Dentifrice</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Toothpaste</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1.5% Arginine Dentifrice</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Toothpaste</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4.0% Arginine Dentifrice</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Toothpaste</description>
  </arm_group>
  <arm_group>
    <arm_group_label>8.0% Arginine Dentifrice</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Toothpaste</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.24% Sodium Fluoride Dentifrice</intervention_name>
    <description>Whole mouth brushing with a toothpaste, 2 times/day for 2 minutes each time for the duration of the study</description>
    <arm_group_label>0.24% Sodium Fluoride Dentifrice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>1.5% Arginine Dentifrice</intervention_name>
    <description>Whole mouth brushing with a toothpaste, 2 times/day for 2 minutes each time for the duration of the study</description>
    <arm_group_label>1.5% Arginine Dentifrice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>4.0% Arginine Dentifrice</intervention_name>
    <description>Whole mouth brushing with a toothpaste, 2 times/day for 2 minutes each time for the duration of the study</description>
    <arm_group_label>4.0% Arginine Dentifrice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>8.0% Arginine Dentifrice</intervention_name>
    <description>Whole mouth brushing with a toothpaste, 2 times/day for 2 minutes each time for the duration of the study</description>
    <arm_group_label>8.0% Arginine Dentifrice</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects meeting all criteria below will be included in the study:&#xD;
&#xD;
               1. Subject assent and parental/guardian informed consent for voluntary&#xD;
                  participation.&#xD;
&#xD;
               2. Willingness and ability to use the assigned products according to instructions,&#xD;
                  availability for all appointments and likelihood of completing the clinical&#xD;
                  trial.&#xD;
&#xD;
               3. Children ages 10-14 years at baseline.&#xD;
&#xD;
               4. Presence of permanent second molars or evidence of at least one permanent second&#xD;
                  molar erupting as indicated by cuspal break through the mucosa.&#xD;
&#xD;
               5. Good general health as evidenced by a review of the medical history.&#xD;
&#xD;
               6. Subjects who, at study entry, have present two or more active caries lesions&#xD;
                  (ICDAS scores of 2 or greater) in permanent teeth and previous caries experience&#xD;
                  (DMFT &gt;1), D= Decayed is defined as ICDAS scores of 3 or greater&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects presenting any of the criteria below will be excluded from the study:&#xD;
&#xD;
               1. Presence of fixed or removable prosthetic appliance or orthodontic treatment&#xD;
                  involving more than four permanent teeth.&#xD;
&#xD;
               2. Use of medication that could increase the risk of developing dental caries, i.e.&#xD;
&#xD;
                  medications that reduce saliva flow and those with high sugar content.&#xD;
&#xD;
               3. Long-term antibiotic therapy.&#xD;
&#xD;
               4. Children with a confirmed diagnosis of cognitive and/or motor impairment.&#xD;
&#xD;
               5. Severe malocclusion.&#xD;
&#xD;
               6. Subjects who, at study entry, have present severe caries (ICDAS 5 or 6) on five&#xD;
                  or more permanent teeth.&#xD;
&#xD;
               7. Evidence of moderate to severe periodontal disease.&#xD;
&#xD;
               8. Participation in any other clinical study within the 30 days preceding the start&#xD;
                  of the clinical study.&#xD;
&#xD;
               9. Known history of allergies or other adverse reactions to arginine, or oral care&#xD;
                  products, or their ingredients.&#xD;
&#xD;
              10. Self-reported history of being currently pregnant, intending to become pregnant&#xD;
                  during the trial period or breast-feeding.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria E Ryan, DDS PhD</last_name>
    <role>Study Director</role>
    <affiliation>Colgate-Palmolive Company</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Domenick T Zero, DDS, MS</last_name>
    <phone>317-274-5429</phone>
    <email>dzero@iu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jennifer Tran</last_name>
    <phone>317-274-3306</phone>
    <email>jelbruce@iu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Loma Linda University School of Dentistry</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92350</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yiming Li, DDS MSD PhD</last_name>
      <phone>909-558-8069</phone>
      <email>yli@llu.edu</email>
    </contact>
    <investigator>
      <last_name>Yiming Li, DDS MSD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Florida College of Dentistry</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marcelle Nascimento, DDS MS PhD</last_name>
      <phone>352-273-5858</phone>
      <email>MNASCIMENTO@dental.ufl.edu</email>
    </contact>
    <investigator>
      <last_name>Marcelle Nascimento, DDS MS PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana University School of Dentistry</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202-2876</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Domenick Zero, DDS MS</last_name>
      <phone>317-274-5429</phone>
      <email>dzero@iu.edu</email>
    </contact>
    <investigator>
      <last_name>Domenick Zero, DDS MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tufts University School of Dental Medicine</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Zandona, DDS MSD PhD</last_name>
      <phone>617-636-0325</phone>
      <email>Andrea.Zandona@tufts.edu</email>
    </contact>
    <investigator>
      <last_name>Andrea Zandona, DDS MSD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Forsyth Institute</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02142</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hatice Hasturk, DDS PhD</last_name>
      <phone>617-892-8499</phone>
      <email>hhasturk@forsyth.org</email>
    </contact>
    <investigator>
      <last_name>Hatice Hasturk, DDS PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University at Buffalo School of Dental Medicine</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Violet I Haraszthy, DDS MS PhD</last_name>
      <phone>716-829-3940</phone>
      <email>vh1@buffalo.edu</email>
    </contact>
    <investigator>
      <last_name>Violet I Haraszthy, DDS MS PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania School of Dental Medicine</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104-6003</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Hershkowitz, DDS AAS</last_name>
      <phone>212-992-7057</phone>
      <email>dhh1@upenn.edu</email>
    </contact>
    <investigator>
      <last_name>David Hershkowitz, DDS AAS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UT Health San Antonio School of Dentistry</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229-3900</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bennett T Amaechi, BDS MSc PhD</last_name>
      <phone>210-567-3185</phone>
      <email>amaechi@uthscsa.edu</email>
    </contact>
    <investigator>
      <last_name>Bennett T Amaechi, BDS MSc PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Puerto Rico School of Dental Medicine</name>
      <address>
        <city>San Juan</city>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Augusto R Elias Boneta, DMD MSD</last_name>
      <phone>787-765-0291</phone>
      <email>dentalresearchassociates@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Augusto R Elias Boneta, DMD MSD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Puerto Rico</country>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>February 8, 2021</study_first_submitted>
  <study_first_submitted_qc>February 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 11, 2021</study_first_posted>
  <last_update_submitted>February 10, 2021</last_update_submitted>
  <last_update_submitted_qc>February 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>fluoride</keyword>
  <keyword>arginine</keyword>
  <keyword>prevention</keyword>
  <keyword>caries</keyword>
  <keyword>ICDAS</keyword>
  <keyword>DMFS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dental Caries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Listerine</mesh_term>
    <mesh_term>Fluorides</mesh_term>
    <mesh_term>Sodium Fluoride</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

